XCOPRI Trademark

Trademark Overview


On Friday, February 24, 2017, a trademark application was filed for XCOPRI with the United States Patent and Trademark Office. The USPTO has given the XCOPRI trademark a serial number of 87349251. The federal status of this trademark filing is REGISTERED as of Tuesday, March 20, 2018. This trademark is owned by SK Biopharmaceuticals Co., Ltd.. The XCOPRI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical [ and veterinary preparations ] for treatment of central nervous system diseases [ , cancer and metabolic diseases ] ; [ sanitary preparations for medical use; ] biological preparations for medical purposes, namely, for the treatment of central nervous system diseases [ , cancer and metabolic diseases ] ; biochemical preparations for medical purposes, namely, for the treatment of central nervous system diseases [ , cancer and metabolic diseases ] ; chemical preparations for pharmaceutical purposes, namely, for the treatment of central nervous system diseases [ , cancer and metabolic diseases ] ; medical preparation of trace elements for human [ and animal ] use, namely, for the treatment of central nervous system diseases [ , cancer and metabolic diseases ] ; [ ferments for pharmaceutical purposes; ] biotechnological preparations for medical purposes, namely, for the treatment of central nervous system diseases [ , cancer and metabolic diseases ] ; [ blood solvent; ] che...
xcopri

General Information


Serial Number87349251
Word MarkXCOPRI
Filing DateFriday, February 24, 2017
Status700 - REGISTERED
Status DateTuesday, March 20, 2018
Registration Number5426093
Registration DateTuesday, March 20, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 2, 2018

Trademark Statements


Goods and ServicesPharmaceutical [ and veterinary preparations ] for treatment of central nervous system diseases [ , cancer and metabolic diseases ] ; [ sanitary preparations for medical use; ] biological preparations for medical purposes, namely, for the treatment of central nervous system diseases [ , cancer and metabolic diseases ] ; biochemical preparations for medical purposes, namely, for the treatment of central nervous system diseases [ , cancer and metabolic diseases ] ; chemical preparations for pharmaceutical purposes, namely, for the treatment of central nervous system diseases [ , cancer and metabolic diseases ] ; medical preparation of trace elements for human [ and animal ] use, namely, for the treatment of central nervous system diseases [ , cancer and metabolic diseases ] ; [ ferments for pharmaceutical purposes; ] biotechnological preparations for medical purposes, namely, for the treatment of central nervous system diseases [ , cancer and metabolic diseases ] ; [ blood solvent; ] chemical preparations for medicinal purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; chemical preparations for medical or veterinary purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; chemical preparations for sanitary use; pharmaceutical preparations for immunity adjustment; vitamin preparations; vaccines; dietary supplements; therapeutic drugs and agents for the treatment of central nervous system diseases, cancer and metabolic diseases; chemico-pharmaceutical preparations for the treatment of central nervous system diseases, cancer and metabolic diseases; [ bacteriological preparations for medical and veterinary use ]

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 3, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSK Biopharmaceuticals Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressGyeonggi-do 13494
KR

Party NameSK Biopharmaceuticals Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeongnam-si
KR

Party NameSK Biopharmaceuticals Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeongnam-si
KR

Trademark Events


Event DateEvent Description
Tuesday, November 28, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 28, 2017NEW APPLICATION ENTERED
Friday, March 3, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 19, 2017ASSIGNED TO EXAMINER
Thursday, May 25, 2017SUSPENSION LETTER WRITTEN
Thursday, May 25, 2017LETTER OF SUSPENSION E-MAILED
Thursday, May 25, 2017NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, November 9, 2017TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, November 22, 2017ASSIGNED TO LIE
Tuesday, November 28, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 4, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 29, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 13, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 2, 2018PUBLISHED FOR OPPOSITION
Tuesday, January 2, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 20, 2018REGISTERED-PRINCIPAL REGISTER
Friday, May 10, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 4, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, September 4, 2020TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, September 4, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 4, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, September 4, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 20, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, January 26, 2024TEAS SECTION 8 & 15 RECEIVED
Monday, August 12, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, August 16, 2024POST REGISTRATION ACTION MAILED - SEC. 8 & 15